CN112603853A - 一种去皱美白面膜 - Google Patents
一种去皱美白面膜 Download PDFInfo
- Publication number
- CN112603853A CN112603853A CN202011643293.7A CN202011643293A CN112603853A CN 112603853 A CN112603853 A CN 112603853A CN 202011643293 A CN202011643293 A CN 202011643293A CN 112603853 A CN112603853 A CN 112603853A
- Authority
- CN
- China
- Prior art keywords
- skin
- wrinkle
- asiaticoside
- sodium hyaluronate
- whitening
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000002087 whitening effect Effects 0.000 title claims abstract description 23
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 33
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 17
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 17
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 claims abstract description 14
- WYQVAPGDARQUBT-FGWHUCSPSA-N Madecassol Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O WYQVAPGDARQUBT-FGWHUCSPSA-N 0.000 claims abstract description 11
- WYQVAPGDARQUBT-XCWYDTOWSA-N asiaticoside Natural products O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@H](O)[C@H](O)[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@H](CO)O2)O1)[C@@]12[C@@H]([C@@H](C)[C@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@@]4(C)[C@H]([C@@](CO)(C)[C@@H](O)[C@H](O)C4)CC3)CC=1)CC2 WYQVAPGDARQUBT-XCWYDTOWSA-N 0.000 claims abstract description 11
- 229940022757 asiaticoside Drugs 0.000 claims abstract description 11
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229960003639 laurocapram Drugs 0.000 claims abstract description 9
- 239000008213 purified water Substances 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 239000000203 mixture Substances 0.000 claims description 14
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 3
- 229960004063 propylene glycol Drugs 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 2
- 210000003491 skin Anatomy 0.000 abstract description 35
- 230000000694 effects Effects 0.000 abstract description 11
- 230000037303 wrinkles Effects 0.000 abstract description 11
- 238000010521 absorption reaction Methods 0.000 abstract description 5
- 208000032544 Cicatrix Diseases 0.000 abstract description 4
- 210000004027 cell Anatomy 0.000 abstract description 4
- 102000004169 proteins and genes Human genes 0.000 abstract description 4
- 108090000623 proteins and genes Proteins 0.000 abstract description 4
- 231100000241 scar Toxicity 0.000 abstract description 4
- 230000037387 scars Effects 0.000 abstract description 4
- 208000028990 Skin injury Diseases 0.000 abstract description 3
- 230000003647 oxidation Effects 0.000 abstract description 3
- 238000007254 oxidation reaction Methods 0.000 abstract description 3
- 210000004927 skin cell Anatomy 0.000 abstract description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 10
- 229920002674 hyaluronan Polymers 0.000 description 10
- 229960003160 hyaluronic acid Drugs 0.000 description 10
- NNWMHSNRRWMMBI-PJISEHJASA-N Asiaticoside B Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](OC[C@@H]2[C@H]([C@H](O)[C@@H](O)[C@H](OC(=O)[C@@]34[C@@H](CC(C)(C)CC3)C=3[C@@]([C@]5(C)C[C@@H](O)[C@H]6[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]6(C)[C@H]5CC=3)(C)CC4)O2)O)[C@H](O)[C@H]1O NNWMHSNRRWMMBI-PJISEHJASA-N 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 5
- 230000003020 moisturizing effect Effects 0.000 description 4
- BNMGUJRJUUDLHW-HCZMHFOYSA-N Madecassoside Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(C[C@@H](O)[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O BNMGUJRJUUDLHW-HCZMHFOYSA-N 0.000 description 3
- BNMGUJRJUUDLHW-HLUHVYOBSA-N Madecassoside Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5[C@H](O)C[C@@]34C)[C@@H]2[C@H]1C)C(=O)O[C@@H]6O[C@H](CO[C@@H]7O[C@H](CO)[C@@H](O[C@@H]8O[C@H](C)[C@H](O)[C@@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@@H](O)[C@H](O)[C@H]6O BNMGUJRJUUDLHW-HLUHVYOBSA-N 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 230000001050 lubricating effect Effects 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- 206010008570 Chloasma Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- -1 anti-inflammation Chemical compound 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 201000010251 cutis laxa Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 150000002632 lipids Chemical group 0.000 description 1
- 238000010999 medical injection Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000003961 penetration enhancing agent Substances 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 230000036558 skin tension Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000036561 sun exposure Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种去皱美白面膜，它包含如下重量比原料：透明质酸钠3％、积雪草苷10％、丙二醇30％、月桂氮酮5％、香精0.2％、纯化水51.8％；本发明具有抗氧化、去皱抗皱美白、修护肌肤损伤疤痕的作用，使皮肤更光洁，促进蛋白质吸收，营养皮肤细胞，使老化的细胞再生，从而起到去皱美白的作用。
Description
技术领域
本发明涉及护肤品技术领域，具体涉及一种去皱美白面膜。
背景技术
随着人们生活水平的逐步提高，人们的生活观念和消费理念也在不断改变，人际之间交流多样化，使人们越来越重视自身的仪表；但是面部肌肤问题困扰着大多数青年男女，面部皮肤问题包括雀斑、晒斑、黄褐斑、褐青色痣、老年斑等，遇到阳光暴晒、化学刺激，内分泌失调等原因还会加重。此外，生活不规律、熬夜等习惯还会造成皮肤暗沉粗糙，皮肤蜡黄暗沉，缺少亮度、干燥缺水，使整个人看起来气色不好。
因此，需要一种去皱美白效果好的面膜。
发明内容
本发明的目的在于针对现有技术的缺陷和不足，提供一种去皱美白面膜。
为实现上述目的，本发明采用的技术方案是：它包含如下重量比原料：透明质酸钠3％、积雪草苷10％、丙二醇30％、月桂氮酮5％、香精0.2％、纯化水51.8％；
进一步地，它的制备方法包含如下步骤：
一、按照各原料的重量份称取备用；
二、将称取的透明质酸钠、积雪草苷、丙二醇、月桂氮酮充分混合，得混合物一，并进行灭菌处理；
三、将混合物一加入纯化水中，再加入香精，搅拌，使其充分混合，得面膜。
进一步地，步骤二中的灭菌方法为：在80-85℃下，保温25-35分钟处理。
采用上述方案后，本发明有益效果为：本发明所述的一种去皱美白面膜，具有抗氧化、去皱抗皱美白、修护肌肤损伤疤痕的作用，使皮肤更光洁，促进蛋白质吸收，营养皮肤细胞，使老化的细胞再生，从而起到去皱美白的作用。
具体实施方式
下面对本发明作进一步的说明。
本具体实施方式采用的技术方案是：一种去皱美白面膜，它包含如下重量比原料：透明质酸钠3％、积雪草苷10％、丙二醇30％、月桂氮酮5％、香精0.2％、纯化水51.8％。
一种去皱美白面膜的制备方法包含如下步骤：
一、按照各原料的重量份称取备用；
二、将称取的透明质酸钠、积雪草苷、丙二醇、月桂氮酮充分混合，得混合物一，在80-85℃下，保温25-35分钟进行灭菌处理；
三、将混合物一加入纯化水中，再加入香精，搅拌，使其充分混合，得面膜。
本发明中的透明质酸钠具有以下功效：
1、吸取水分：透明质酸钠中的透明质酸能帮助肌肤汲取大量的水分，肌肤有了水分，自然就能保持弹性和柔软。现有技术只能通过医学注射手段为肌肤补充透明质酸。本发明将少量的透明质酸作为保湿剂，将百万分子量透明质酸压缩打包作用于肌肤，就能吸收约相当于自身重量1000倍的水，令表皮细胞再度充盈，抚平皱纹；见效时间虽比不上直接注射，但却可以每日不断补充，让细胞自然充盈起来；
2、修复及保水：透明质酸钠中的透明质酸可瞬间深层保湿、增加皮肤弹性与张力，有助恢复肌肤正常油水平衡，改善干燥及松弛皮肤；透明质酸也是肌肤中的一种重要成份，具有表皮组织修复的功能；当皮肤组织暴露在UVB射线下时，皮肤会晒伤、发炎，真皮组织会停止产生透明质酸，同时加快透明质酸的衰退率；透明质酸大量存在于人体的结缔组织及真皮层中，拥有强大的吸水能力和保湿功能，还能增强皮肤长时间的保水能力，能帮助弹力纤维以及胶原蛋白处在充满水分的环境中，让皮肤显的更有弹性；
3、营养作用：透明质酸钠是皮肤固有的生物物质，外源性的透明质酸钠是对皮肤内源性的补充；较小的透明质酸钠可渗入皮肤表皮层，促进皮肤营养的供给和废物的排泄，从而防止皮肤老化，起到美容和养颜作用；
4、润滑性和成膜性：透明质酸钠属于高分子聚合物，具有很强的润滑感和成膜性；含透明质酸钠的护肤品涂抹时润滑感明显，手感良好；涂于皮肤后，可在皮肤表面形成一层薄膜，使皮肤产生良好的光滑感和湿润感，对皮肤起到保护作用；
5、增稠性：透明质酸钠在水溶液中具有很高的粘度，其1％的水溶液呈凝胶状，添加在化妆品中可起增稠和稳定作用。
本发明中的积雪草苷具有以下功效：积雪草苷A与积雪草苷B的混合物具有促进伤口愈合、抗皱、抗炎、抗抑郁、促进智力等药理作用；比较积雪草苷促进伤口愈合，治疗疤痕的药理作用可以发现，积雪草总皂苷的抗炎、抗抑郁、促进智力等药理作用可能是积雪草苷A与积雪草苷B起了主要作用；同时还有研究表明，不同浓度以及不同质量组成的积雪草苷A与积雪草苷B混合物的抗炎药理具有明显的差异。
本发明中的丙二醇主要作为保湿剂、溶剂、增溶剂使用；丙二醇是小分子保湿成分，能锁住水分，起到保湿的作用；丙二醇除了具备保湿功效，还具备促进肌肤吸收的功效，可以充当渗透剂使用，让护肤品的成分更好的被肌肤吸收。
本发明中的月桂氮酮作为皮肤渗透促进剂，能改变皮肤色质层脂质与蛋白结构，促进药物经皮肤吸收，对亲水性和疏水性的化合物都能增强其透皮作用。
本发明所述的去皱美白面膜，将透明质酸钠、积雪草苷、丙二醇、月桂氮酮、香精、纯化水进行科学配方和组合，具有抗氧化、去皱抗皱美白、修护肌肤损伤疤痕的作用，使皮肤更光洁，促进蛋白质吸收，营养皮肤细胞，使老化的细胞再生，从而起到去皱美白的作用，去皱美白效果明显。
以上所述，仅用以说明本发明的技术方案而非限制，本领域普通技术人员对本发明的技术方案所做的其它修改或者等同替换，只要不脱离本发明技术方案的精神和范围，均应涵盖在本发明的权利要求范围当中。
Claims (3)
1.一种去皱美白面膜，其特征在于它包含如下重量比原料：透明质酸钠3％、积雪草苷10％、丙二醇30％、月桂氮酮5％、香精0.2％、纯化水51.8％。
2.根据权利要求1所述的一种去皱美白面膜，其特征在于它的制备方法包含如下步骤：
一、按照各原料的重量份称取备用；
二、将称取的透明质酸钠、积雪草苷、丙二醇、月桂氮酮充分混合，得混合物一，并进行灭菌处理；
三、将混合物一加入纯化水中，再加入香精，搅拌，使其充分混合，得面膜。
3.根据权利要求2所述的一种去皱美白面膜，其特征在于步骤二中的灭菌方法为：在80-85℃下，保温25-35分钟处理。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011643293.7A CN112603853A (zh) | 2020-12-30 | 2020-12-30 | 一种去皱美白面膜 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011643293.7A CN112603853A (zh) | 2020-12-30 | 2020-12-30 | 一种去皱美白面膜 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112603853A true CN112603853A (zh) | 2021-04-06 |
Family
ID=75253416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011643293.7A Pending CN112603853A (zh) | 2020-12-30 | 2020-12-30 | 一种去皱美白面膜 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112603853A (zh) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102247308A (zh) * | 2011-06-14 | 2011-11-23 | 北京华夏众芳生物科技有限公司 | 一种具有促渗功效的中药组合物、制剂及其制备方法 |
| CN103637967A (zh) * | 2013-11-30 | 2014-03-19 | 苏州市洋海电子有限公司 | 美白面膜 |
| CN110251419A (zh) * | 2019-06-24 | 2019-09-20 | 南方医科大学 | 具有美白修复作用的中药活性成分组合物面膜及其制备方法 |
| CN110960467A (zh) * | 2019-12-30 | 2020-04-07 | 河南汇博医疗股份有限公司 | 一种无菌面膜及其制备方法 |
-
2020
- 2020-12-30 CN CN202011643293.7A patent/CN112603853A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102247308A (zh) * | 2011-06-14 | 2011-11-23 | 北京华夏众芳生物科技有限公司 | 一种具有促渗功效的中药组合物、制剂及其制备方法 |
| CN103637967A (zh) * | 2013-11-30 | 2014-03-19 | 苏州市洋海电子有限公司 | 美白面膜 |
| CN110251419A (zh) * | 2019-06-24 | 2019-09-20 | 南方医科大学 | 具有美白修复作用的中药活性成分组合物面膜及其制备方法 |
| CN110960467A (zh) * | 2019-12-30 | 2020-04-07 | 河南汇博医疗股份有限公司 | 一种无菌面膜及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104800120B (zh) | 一种抗衰填充细纹护肤精华液 | |
| CA2639525A1 (en) | Topical composition for the protection and/or treatment of radiation related skin damages | |
| CN104983646A (zh) | 夜用养护面膜液及其制备方法 | |
| CN104983647A (zh) | 深层修复面膜及其制备方法 | |
| CN104434768A (zh) | 一种具有缓释功效的保湿化妆水及其制备方法 | |
| CN104983648A (zh) | 修复紫外线灼伤皮肤的面膜及其制备方法 | |
| CN111840124A (zh) | 寡肽水感靓肤面膜及其精华液及精华液的制备方法 | |
| CN111012691A (zh) | 一种医用冷敷贴面膜 | |
| CN104771340B (zh) | 一种抗衰填充细纹的面膜 | |
| KR101165848B1 (ko) | 효소 및 아미노산을 함유하는 피부 화장료 조성물 | |
| CN113975197A (zh) | 一种含有聚谷氨酸钠的组合物及其应用的敷料 | |
| CN104490713A (zh) | 一种具有排浊紧致和抗皱活化肌肤功能的超软活泉护肤品 | |
| CN114259419B (zh) | 一种含重组胶原蛋白的复配组合物及其制备方法和应用 | |
| CN111514036A (zh) | 一种提拉紧致抗衰老面膜及其制备方法 | |
| KR20220114509A (ko) | 세정제 조성물 및 그에 의해 제조된 올인원 세정제 | |
| CN113797110A (zh) | 一种含羟丙基四氢吡喃三醇、硫代牛磺酸的抗衰老组合物及其应用 | |
| CN103520017A (zh) | 一种除皱抗衰、活化肌肤、修复美白的组合物 | |
| CN108478464A (zh) | 一种美肤肽面膜液及其制作方法 | |
| KR101042712B1 (ko) | 피부 재생 및 상처 치유용 화장료 조성물 | |
| CN116509750A (zh) | 一种复合鱼胶原蛋白面膜液及制备方法 | |
| CN112603853A (zh) | 一种去皱美白面膜 | |
| CN115957149A (zh) | 水光针精华及其制备方法 | |
| CN105411973A (zh) | 一种纳米珍珠粉/透明质酸钠复合保湿粒子的制备方法 | |
| KR101917026B1 (ko) | 피부 주름 개선 또는 예방용 화장료 조성물 | |
| CN114522232A (zh) | 促进皮肤伤口愈合配方、乳液 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210406 |